nm23-H1 protein expression and gene mutation in 150 patients with non-Hodgkin's lymphomas

Ju-Han Lee, Jin Cho Su, Xianglan Zhang, Zhenlong Zheng, Eung Seok Lee, Aeree Kim, Young Sik Kim, Yang Seok Chae, Insun Kim

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The metastasis-suppressing role of the nm23 gene in the metastatic spread of malignant tumor is still debated. We examined the nm23-H1 protein expression and gene mutation in non-Hodgkin's lymphomas to compare with the clinicopathologic parameters. The expression of nm23-H1 protein was immunohistochemically examined in 150 cases of non-Hodgkin's lymphomas; 85 diffuse large B cell lymphomas (DLBCL), 18 marginal zone B cell lymphomas (MZL), 3 mantle cell lymphomas, 25 peripheral T cell lymphomas, not otherwise specified (TCLNOS), and 19 NK/T cell lymphomas (NK/T). Eighty-one cases (58 DLBCL, 6 MZL, 4 TCLNOS, and 13 NK/T) were studied for nm23-H1 gene mutation in exon 1 to 5. The high expression of nm23-H1 protein was associated with the high IPI score (p=0.019) and the low survival rate of the patients (p=0.0039). The gene mutation of nm23-H1 was detected in 10.3% of DLBCL and 30.7% of NK/T; but none in MZL and TCLNOS. The mutation was found in exon 1 in 5 cases, exon 2 in two cases, exon 4 in one case and both exon 1 and 2 in two cases. Our results suggest that the expression of nm23-H1 protein can be used as a poor prognostic marker in non-Hodgkin's lymphomas, and the mutational change of gene may operate in the lymphomagenesis.

Original languageEnglish
Pages (from-to)645-651
Number of pages7
JournalJournal of Korean Medical Science
Volume21
Issue number4
Publication statusPublished - 2006 Aug 15

Fingerprint

Non-Hodgkin's Lymphoma
Exons
Lymphoma, Large B-Cell, Diffuse
T-Cell Lymphoma
Gene Expression
Mutation
Proteins
Genes
Peripheral T-Cell Lymphoma
Mantle-Cell Lymphoma
Marginal Zone B-Cell Lymphoma
Natural Killer Cells
Survival Rate
Neoplasm Metastasis
Neoplasms

Keywords

  • Lymphoma, Non-Hodgkin
  • Mutation
  • nm23-H1 Protein
  • Nucleoside diphosphate kinase A
  • Prognosis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

nm23-H1 protein expression and gene mutation in 150 patients with non-Hodgkin's lymphomas. / Lee, Ju-Han; Su, Jin Cho; Zhang, Xianglan; Zheng, Zhenlong; Lee, Eung Seok; Kim, Aeree; Kim, Young Sik; Chae, Yang Seok; Kim, Insun.

In: Journal of Korean Medical Science, Vol. 21, No. 4, 15.08.2006, p. 645-651.

Research output: Contribution to journalArticle

@article{0f468f68acff4f2c8b6a92e6c5e8dd29,
title = "nm23-H1 protein expression and gene mutation in 150 patients with non-Hodgkin's lymphomas",
abstract = "The metastasis-suppressing role of the nm23 gene in the metastatic spread of malignant tumor is still debated. We examined the nm23-H1 protein expression and gene mutation in non-Hodgkin's lymphomas to compare with the clinicopathologic parameters. The expression of nm23-H1 protein was immunohistochemically examined in 150 cases of non-Hodgkin's lymphomas; 85 diffuse large B cell lymphomas (DLBCL), 18 marginal zone B cell lymphomas (MZL), 3 mantle cell lymphomas, 25 peripheral T cell lymphomas, not otherwise specified (TCLNOS), and 19 NK/T cell lymphomas (NK/T). Eighty-one cases (58 DLBCL, 6 MZL, 4 TCLNOS, and 13 NK/T) were studied for nm23-H1 gene mutation in exon 1 to 5. The high expression of nm23-H1 protein was associated with the high IPI score (p=0.019) and the low survival rate of the patients (p=0.0039). The gene mutation of nm23-H1 was detected in 10.3{\%} of DLBCL and 30.7{\%} of NK/T; but none in MZL and TCLNOS. The mutation was found in exon 1 in 5 cases, exon 2 in two cases, exon 4 in one case and both exon 1 and 2 in two cases. Our results suggest that the expression of nm23-H1 protein can be used as a poor prognostic marker in non-Hodgkin's lymphomas, and the mutational change of gene may operate in the lymphomagenesis.",
keywords = "Lymphoma, Non-Hodgkin, Mutation, nm23-H1 Protein, Nucleoside diphosphate kinase A, Prognosis",
author = "Ju-Han Lee and Su, {Jin Cho} and Xianglan Zhang and Zhenlong Zheng and Lee, {Eung Seok} and Aeree Kim and Kim, {Young Sik} and Chae, {Yang Seok} and Insun Kim",
year = "2006",
month = "8",
day = "15",
language = "English",
volume = "21",
pages = "645--651",
journal = "Journal of Korean Medical Science",
issn = "1011-8934",
publisher = "Korean Academy of Medical Science",
number = "4",

}

TY - JOUR

T1 - nm23-H1 protein expression and gene mutation in 150 patients with non-Hodgkin's lymphomas

AU - Lee, Ju-Han

AU - Su, Jin Cho

AU - Zhang, Xianglan

AU - Zheng, Zhenlong

AU - Lee, Eung Seok

AU - Kim, Aeree

AU - Kim, Young Sik

AU - Chae, Yang Seok

AU - Kim, Insun

PY - 2006/8/15

Y1 - 2006/8/15

N2 - The metastasis-suppressing role of the nm23 gene in the metastatic spread of malignant tumor is still debated. We examined the nm23-H1 protein expression and gene mutation in non-Hodgkin's lymphomas to compare with the clinicopathologic parameters. The expression of nm23-H1 protein was immunohistochemically examined in 150 cases of non-Hodgkin's lymphomas; 85 diffuse large B cell lymphomas (DLBCL), 18 marginal zone B cell lymphomas (MZL), 3 mantle cell lymphomas, 25 peripheral T cell lymphomas, not otherwise specified (TCLNOS), and 19 NK/T cell lymphomas (NK/T). Eighty-one cases (58 DLBCL, 6 MZL, 4 TCLNOS, and 13 NK/T) were studied for nm23-H1 gene mutation in exon 1 to 5. The high expression of nm23-H1 protein was associated with the high IPI score (p=0.019) and the low survival rate of the patients (p=0.0039). The gene mutation of nm23-H1 was detected in 10.3% of DLBCL and 30.7% of NK/T; but none in MZL and TCLNOS. The mutation was found in exon 1 in 5 cases, exon 2 in two cases, exon 4 in one case and both exon 1 and 2 in two cases. Our results suggest that the expression of nm23-H1 protein can be used as a poor prognostic marker in non-Hodgkin's lymphomas, and the mutational change of gene may operate in the lymphomagenesis.

AB - The metastasis-suppressing role of the nm23 gene in the metastatic spread of malignant tumor is still debated. We examined the nm23-H1 protein expression and gene mutation in non-Hodgkin's lymphomas to compare with the clinicopathologic parameters. The expression of nm23-H1 protein was immunohistochemically examined in 150 cases of non-Hodgkin's lymphomas; 85 diffuse large B cell lymphomas (DLBCL), 18 marginal zone B cell lymphomas (MZL), 3 mantle cell lymphomas, 25 peripheral T cell lymphomas, not otherwise specified (TCLNOS), and 19 NK/T cell lymphomas (NK/T). Eighty-one cases (58 DLBCL, 6 MZL, 4 TCLNOS, and 13 NK/T) were studied for nm23-H1 gene mutation in exon 1 to 5. The high expression of nm23-H1 protein was associated with the high IPI score (p=0.019) and the low survival rate of the patients (p=0.0039). The gene mutation of nm23-H1 was detected in 10.3% of DLBCL and 30.7% of NK/T; but none in MZL and TCLNOS. The mutation was found in exon 1 in 5 cases, exon 2 in two cases, exon 4 in one case and both exon 1 and 2 in two cases. Our results suggest that the expression of nm23-H1 protein can be used as a poor prognostic marker in non-Hodgkin's lymphomas, and the mutational change of gene may operate in the lymphomagenesis.

KW - Lymphoma, Non-Hodgkin

KW - Mutation

KW - nm23-H1 Protein

KW - Nucleoside diphosphate kinase A

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=33746899643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746899643&partnerID=8YFLogxK

M3 - Article

VL - 21

SP - 645

EP - 651

JO - Journal of Korean Medical Science

JF - Journal of Korean Medical Science

SN - 1011-8934

IS - 4

ER -